Logo

American Heart Association

  146
  0


Final ID: MP35

Community Prevalence of the Cardiovascular-Kidney-Metabolic (CKM) Syndrome: The Dallas Heart Study

Abstract Body: Introduction: The recent AHA presidential advisory on Cardiovascular-Kidney-Metabolic Syndrome (CKM) proposed a novel staging scheme, but limited data exist regarding CKM stage prevalence in the community. Prior population-based studies have lacked subclinical imaging measures, and have not reported variability by age, gender, and race/ethnicity.

Methods: We estimated the population prevalence of CKM stages in Dallas County, from among 2,817 participants in the population-sampled Dallas Heart Study who attended study Visit 1 (2000-2002). Participants underwent protocol measurement of body composition, lipids, fasting blood sugar, serum creatinine, NT-proBNP, hs-cTnT, urinary albumin and creatinine, coronary artery calcium by cardiac CT (CAC), and cardiac function and mass by cardiac MRI. These were used to operationalize the following CKM stages: 0 – no CKM risk factors; 1 – excess or dysfunctional adiposity (body mass index, waist circumference, and fasting blood glucose); 2 – metabolic risk factors (hypertriglyceridemia, hypertension, diabetes, metabolic syndrome) and chronic kidney disease; 3 – subclinical cardiovascular diseases (CAC, LV hypertrophy or dysfunction by cardiac MRI, elevated cardiac biomarkers (NT-proBNP or hs-cTnT), high AHA-PREVENT or KDIGO scores); 4 – prevalent cardiovascular diseases (coronary heart disease, heart failure, atrial fibrillation, stroke). We used sampling weights to estimate the prevalence of CKM stages in Dallas County in 2000-2002 overall and by age category (30-44, 45-59, 60-65 years), gender, and race/ethnicity.

Results: Among the 2,817 participants with a mean age of 44±10 years, the sample weighted demographics were 50% women, 52% non-Hispanic White, 20% non-Hispanic Black, and 26% Hispanic race/ethnicity. Among Dallas County adults, only 10% were CKM Stage 0 (no risk factors). The weighted prevalence of CKM Stages 1 through 4 was 16%, 46%, 23%, and 5%, respectively (Figure A). CKM stage prevalence was similar between men and women, while CKM Stage 4 was more frequent among older individuals and among non-Hispanic Black compared with non-Hispanic White and Hispanic individuals (Figure B).

Conclusion: The public health burden of CKM is substantial. Ninety percent of Dallas County residents in 2000-2002 had some form of CKM syndrome, nearly half demonstrated metabolic dysfunction (Stage 2), and nearly one-fourth had subclinical cardiovascular disease (Stage 3).
  • Shelbaya, Khaled  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • De Lemos, James  ( UT SOUTHWESTERN MEDICAL CTR , Dallas , Texas , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Zeleke, Yinun  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Lamberson, Victoria  ( UT Southwestern Medical Center , Yorktown , Virginia , United States )
  • Yang, Yimin  ( Brigham and Women's Hospital , Woodland , California , United States )
  • Ayers, Colby  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Neeland, Ian  ( University Hospitals - Case Western , Cleveland , Ohio , United States )
  • Rohatgi, Anand  ( UT SOUTHWESTERN , Dallas , Texas , United States )
  • Joshi, Parag  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Khera, Amit  ( UT Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Khaled Shelbaya: DO have relevant financial relationships ; Researcher:Alexion:Expected (by end of conference) | James de Lemos: No Answer | Amil Shah: DO NOT have relevant financial relationships | Yinun Zeleke: No Answer | Victoria Lamberson: DO NOT have relevant financial relationships | Yimin Yang: DO NOT have relevant financial relationships | Colby Ayers: DO have relevant financial relationships ; Consultant:NIH:Active (exists now) | Ian Neeland: No Answer | Anand Rohatgi: No Answer | Parag Joshi: No Answer | Amit Khera: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

MP06. Cardiometabolic Health and Disorders

Friday, 03/07/2025 , 05:00PM - 07:00PM

Moderated Poster Session

More abstracts on this topic:
Association of Bone Mineral Density with Progression and Incidence of Aortic Calcification: the ERA JUMP Study

Carlson Lauren, Kadota Aya, Kadowaki Sayaka, Kondo Keiko, Miura Katsuyuki, Fujiyoshi Akira, Hisamatsu Takashi, Okamura Tomonori, Sekikawa Akira, Li Mengyi, Li Jiatong, Leader Joseph, Bon Jessica, Edmundowicz Daniel, Masaki Kamal, Willcox Bradley, Seto Todd

A validated metabolite-based biomarker score for fruit and vegetable intake and associations with all-cause mortality and incident cardiometabolic diseases

Oude Griep Linda, Li Chunxiao, Koulman Albert, Imamura Fumiaki, Wareham Nicholas, Forouhi Nita

More abstracts from these authors:
Progression in Cardiovascular-Kidney-Metabolic (CKM) Stages Over 7 Years in Mid-Life: The Dallas Heart Study

Shelbaya Khaled, Neeland Ian, Ndumele Chiadi, Shah Amil, Yang Yimin, Zeleke Yinun, Lamberson Victoria, Joshi Parag, Rohatgi Anand, Ayers Colby, Khera Amit, De Lemos James

Prognosis of Cardiovascular-Kidney-Metabolic (CKM) Stages: The Dallas Heart Study

Shelbaya Khaled, Neeland Ian, Ndumele Chiadi, Shah Amil, Yang Yimin, Lamberson Victoria, Zeleke Yinun, Joshi Parag, Rohatgi Anand, Ayers Colby, Khera Amit, De Lemos James

You have to be authorized to contact abstract author. Please, Login
Not Available